Cosmos Health (COSM) Net Income towards Common Stockholders (2010 - 2026)
Cosmos Health (COSM) recorded quarterly Net Income towards Common Stockholders of -$2.8 million in Q1 2026, up 69.12% on a QoQ basis from -$9.1 million in Q4 2025, and down 242.92% year-over-year from $2.0 million in Q1 2025.
Cosmos Health (COSM) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Cosmos Health has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting -$2.8 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 242.92% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.1 million (up 5.9% YoY) and the FY2025 annual result came in at -$19.1 million, up 14.45% from the prior year.
- Net Income towards Common Stockholders rose to -$2.8 million in Q1 2026, from -$9.1 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$459863.0 in Q1 2023 and troughed at -$38.1 million in Q4 2022.
- A 5-year average of -$7.8 million and a median of -$3.4 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 667.7% — and 2023, when it surged 94.63%.
- Tracing COSM's Net Income towards Common Stockholders over 5 years: stood at -$38.1 million in 2022, then surged by 44.94% to -$21.0 million in 2023, then soared by 54.51% to -$9.5 million in 2024, then increased by 4.81% to -$9.1 million in 2025, then jumped by 69.12% to -$2.8 million in 2026.
- Business Quant data shows COSM's Net Income towards Common Stockholders at -$2.8 million in Q1 2026, -$9.1 million in Q4 2025, and -$5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 1.86 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 380.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -541.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -9.08 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -2.32 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.81 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81 Mn |
| Dec 31, 2025 | -9.08 Mn |
| Sep 30, 2025 | -5.35 Mn |
| Jun 30, 2025 | -2.83 Mn |
| Mar 31, 2025 | -818,097.00 |
| Dec 31, 2024 | -9.54 Mn |
| Sep 30, 2024 | -8.38 Mn |
| Jun 30, 2024 | -2.59 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -20.98 Mn |
| Sep 30, 2023 | -3.36 Mn |
| Jun 30, 2023 | -981,530.00 |
| Mar 31, 2023 | -459,863.00 |
| Dec 31, 2022 | -38.10 Mn |
| Sep 30, 2022 | -1.99 Mn |
| Jun 30, 2022 | -18.26 Mn |
| Mar 31, 2022 | -5.59 Mn |
| Dec 31, 2021 | -9.11 Mn |
| Sep 30, 2021 | -1.94 Mn |
| Jun 30, 2021 | -2.38 Mn |